期刊文献+

基于UPLC-oaTOF-MS的糖尿病及糖尿病肾病的代谢组学研究 被引量:19

Metabonomics Research of Diabetes Mellitus and Diabetic Nephropathy Based on UPLC-oaTOF-MS System
下载PDF
导出
摘要 Ultra performance liquid chromatography(UPLC) coupled with orthogonal acceleration time-of-flight(oaTOF) mass spectrometry is becoming an effective and high-throughput analytical technique in metabonomics research.In this paper,an UPLC-oaTOF-MS system was employed to investigate the serum profiles of 40 diabete mellitus(DM)/diabetic nephropathy(DN) patients and 25 healthy volunteers in an effort to find potential biomarkers.The UPLC system produced information-rich chromatograms with typical measured peak widths of 4 s,and generated peak capacities of 225 in 15 min.After the UPLC-oaTOF-MS analysis,principal component analysis(PCA) was used for group differentiation and marker selection.In the projection of positive mode,DM/DN patients and the controls were obviously divided into three groups.Furthermore,two potential markers were identified as phytosphingosine and sphinganine,respectively.Phytosphingosine and sphinganine with decreased concentrations in the patients,were closely related to the sphingolipid metabolism. Ultra performance liquid chromatography (UPLC) coupled with orthogonal acceleration time-of- flight(oaTOF) mass spectrometry is becoming an effective and high-throughput analytical technique in metabonomics research. In this paper, an UPLC-oaTOF-MS system was employed to investigate the serum profiles of 40 diabete mellitus(DM)/diabetic nephropathy (DN) patients and 25 healthy volunteers in an effort to find potential biomarkers. The UPLC system produced information-rich chromatograms with typical measured peak widths of 4 s, and generated peak capacities of 225 in 15 min. After the UPLC-oaTOF-MS analysis, principal component analysis (PCA) was used for group differentiation and marker selection. In the projection of positive mode, DM/DN patients and the controls were obviously divided into three groups. Furthermore, two potential markers were identified as phytosphingosine and sphinganine, respectively. Phytosphingosine and sphinganine with decreased concentrations in the patients, were closely related to the sphingolipid metabolism.
出处 《高等学校化学学报》 SCIE EI CAS CSCD 北大核心 2008年第11期2171-2173,共3页 Chemical Journal of Chinese Universities
基金 中国博士后科学基金(批准号:20080430108) 国家自然科学基金(批准号:20775063)资助
关键词 糖尿病 糖尿病肾病 代谢组学 超高效液相色谱 飞行时间质谱 Diabete mellitus Diabetic nephropathy Metabonomics Ultra performance liquid chromatography Time-of-flight mass spectrometer
  • 相关文献

参考文献10

  • 1Nicholson J. K., Connelly J., Lindon J. C., et al.. Nat. Rev. Drug. Disc. [J], 2002, 1:153--161.
  • 2Salek R. M.. Maguire M. L.. Griffin J. L. , et al.. Physiol. Genomics[J] , 2007, 29:99--108.
  • 3Makinen V. , Soininen P. , Forsblom C. , et al.. Magn. Reson. Mater. Phy. [J] , 2006, 19:281--296.
  • 4林艳萍,司端运,刘昌孝.液相色谱和质谱联用技术结合化学计量学应用于代谢组学的研究进展[J].分析化学,2007,35(10):1535-1540. 被引量:26
  • 5Wilson I ,D. , Plumb R. , Granger J. , et al.. J. Chromatogr. B[J], 2005, 817:67--76.
  • 6Wang C. , Kong H. W. , Xu G. W. , et al.. Anal. Chem. [J], 2005, 77:4108--4116.
  • 7Williams R. E. , Lenz E. M. , Evans J. A. , et al.. J. Pharm. Biomed. Anal. [J], 2005, 38(3) : 465-471.
  • 8Issaq H. J. , Abbott E. , Veenstra T. D.. J. Sep. Sci. [J], 2008, 31(11) : 1936--1947.
  • 9Wishart D. S. , Tzur D. , Knox C. , et al.. Nucleic Acids Research[J] , 2007, 35:D521--D526.
  • 10Fox T. E. ,Han X. L. , Kelly S. , et al.. Diabetes[J] , 2006, 55:3573--3580.

二级参考文献48

  • 1刘昌孝.代谢组学的发展与药物研究开发[J].天津药学,2005,17(2):1-6. 被引量:60
  • 2尹恒,李曙光,白雪芳,杜昱光.植物代谢组学的研究方法及其应用[J].植物学通报,2005,22(5):532-540. 被引量:31
  • 3李晶,吴晓健,刘昌孝,元英进.代谢组学研究中数据处理新方法的应用[J].药学学报,2006,41(1):47-53. 被引量:43
  • 4谢跃生,潘桂湘,高秀梅,刘昌孝.高效液相色谱技术在代谢组学研究中的应用[J].分析化学,2006,34(11):1644-1648. 被引量:25
  • 5Nicholson J K, Lindon J C, Holmes E. Xenobiotica, 1999, 29:1181 -1189.
  • 6Thomas G H. Trends Microbio. , 2001, 9:255.
  • 7Lindon J C, Nieholson J K, Holmes E, Antti H, Bollard M E, Keun H, Beekonert O, Ebbels T M, Rely M D, Robertson D, Stevens G J, Luke P, Breau A P, Cantor G H, Bible R H, Niederhauser U, Senn H,Sehlotterbeeh G, Sidelmann U G, Laursen S M, Tymiak A, Car B D, Lehman-McKeeman L, Colet J M, Loukaei A, Thomas C. Toxicol. Appl. Pharmacol. , 2003, 187 : 137 - 146.
  • 8Lindon J C, Keun H C, Ebbels T M, Perce J M, Holmes E, Nicholson J K. Pharmacogenomics, 2005, 6:691 -699.
  • 9Lafaye A, Junot C, Ramounet-Le Gall B, Fritsch P, Tabet J C, Ezan E. Rapid Commun. Mass Spectrom. , 2003, 17: 2541-2549.
  • 10Watkins S M, Reifsnyder P R, Pan H J, German J B, Leiter E H. J. Lipid Res. , 2002, 43 : 1809 - 1817.

共引文献25

同被引文献273

引证文献19

二级引证文献159

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部